Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FSD1L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | PSIP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | NIP7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | GUCY1A3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ZSCAN5A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | KMT5C | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | DKK1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | H2AFY | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | DPY19L3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |